(ROOT (S (S (NP (DT A) (@NP (JJ new) (@NP (NN cancer) (NN drug)))) (VP (@VP (VBD proved) (ADJP (RB strikingly) (@ADJP (JJ successful) (PP (IN with) (NP (ADJP (RB very) (JJ few)) (@NP (JJ side) (NNS effects))))))) (PP (IN in) (S (VP (VBG treating) (NP (NP (DT a) (@NP (ADJP (RB relatively) (JJ rare)) (NN form))) (PP (IN of) (NP (NN leukemia))))))))) (@S (, ,) (@S (NP (NNS researchers)) (@S (VP (VBD said)) (. .))))))
(ROOT (S (NP (@NP (@NP (NP (DT The) (NN drug)) (, ,)) (VP (VBN called) (NP (NN 2-CdA)))) (, ,)) (@S (VP (@VP (VBD was) (ADJP (NP (QP (RB nearly) (CD 100)) (NN %)) (JJ effective))) (S (VP (@VP (VBG treating) (NP (CD 12) (NNS patients))) (PP (IN with) (NP (JJ hairy-cell) (NN leukemia)))))) (. .))))
(ROOT (S (NP (DT The) (NNS patients)) (@S (VP (@VP (VP (@VP (VBD underwent) (ADVP (RB just))) (NP (CD one) (@NP (JJ seven-day) (NN treatment)))) (CC and)) (VP (VBD experienced) (NP (NP (RB almost) (NN none)) (PP (IN of) (NP (@NP (NP (DT the) (@NP (JJ debilitating) (@NP (NN side) (NNS effects)))) (PP (JJ such) (@PP (IN as) (NP (NN vomiting) (@NP (, ,) (@NP (NN hair-loss) (@NP (CC and) (@NP (NN kidney) (@NP (CC and) (@NP (NN liver) (NNS problems))))))))))) (VP (VBN associated) (PP (IN with) (NP (JJ other) (NN chemotherapy))))))))) (. .))))
(ROOT (S (@S (@S (@S (S (NP (DT The) (NNS results)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (@VP (VBN replicated) (PP (IN by) (NP (JJ other) (NNS researchers)))) (SBAR (IN before) (S (NP (JJ definitive) (NNS conclusions)) (VP (MD can) (VP (VB be) (VP (VBN made)))))))))))) (, ,)) (CC and)) (S (NP (NP (DT the) (@NP (JJ long-term) (NN effect))) (PP (IN of) (NP (DT the) (NN treatment)))) (VP (VBZ remains) (ADJP (JJ unknown))))) (. .)))
(ROOT (S (CC But) (@S (@S (@S (@S (S (NP (NP (DT the) (@NP (JJ initial) (NN experience))) (PP (IN with) (NP (DT the) (NN compound)))) (VP (VBZ is) (ADJP (RB especially) (JJ promising)))) (, ,)) (CC and)) (S (NP (NP (DT an) (@NP (JJ apparent) (NN improvement))) (PP (IN over) (NP (NP (JJ other) (NN therapy)) (PP (IN for) (NP (@NP (NP (DT the) (NN disease)) (, ,)) (NP (NNS scientists))))))) (VP (VBD said)))) (. .))))
(ROOT (SINV (`` ``) (@SINV (S (NP (EX There)) (VP (@VP (VBP are) (RB n't)) (NP (NP (JJ many) (@NP (-LRB- -LCB-) (@NP (NNS drugs) (-RRB- -RCB-)))) (SBAR (WHADVP (WRB where)) (S (NP (PRP you)) (VP (@VP (@VP (VP (MD can) (VP (VB administer) (NP (NP (CD one) (NN course)) (PP (IN of) (NP (NN treatment)))))) (CC and)) (VP (VBP have) (NP (DT the) (NN disease)))) (VP (@VP (VP (VB go) (ADVP (RB away))) (CC and)) (VP (@VP (VB stay) (ADVP (RB away))) (PP (IN for) (NP (QP (RB as) (@QP (JJ long) (@QP (IN as) (CD four)))) (NNS years))))))))))) (@SINV (, ,) (@SINV ('' '') (@SINV (@SINV (VP (VBZ says)) (NP (@NP (NP (NNP Lawrence) (NNP Piro)) (, ,)) (NP (NP (NN chief)) (PP (IN of) (NP (NP (NN cancer) (NN research)) (PP (IN at) (NP (@NP (@NP (@NP (@NP (@NP (NP (NNP Scripps) (@NP (NNP Clinic) (@NP (CC &) (@NP (NNP Research) (NNP Foundation))))) (, ,)) (NP (NNP La) (NNP Jolla))) (, ,)) (NP (NNP Calif.))) (, ,)) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN drug)) (VP (VBD was) (VP (VBN developed)))))))))))) (. .)))))))
(ROOT (S (`` ``) (@S (NP (DT The) (NN leukemia)) (@S (@S (VP (@VP (VBZ has) (RB n't)) (VP (@VP (VB come) (ADVP (RB back))) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (SBAR (S (NP (PRP we)) (VP (VBD treated)))))))))) (. .)) ('' '')))))
(ROOT (S (NP (DT The) (NN study)) (@S (VP (VBZ is) (VP (VBN published) (PP (IN in) (NP (NP (NP (NN today) (POS 's)) (@NP (NNP New) (@NP (NNP England) (NNP Journal)))) (PP (IN of) (NP (NNP Medicine))))))) (. .))))
(ROOT (SINV (`` ``) (@SINV (S (NP (PRP It)) (VP (@VP (VBZ is) (PP (IN without) (NP (NN doubt)))) (NP (@NP (@NP (NP (DT the) (@NP (ADJP (RBS most) (JJ effective)) (NN treatment))) (PP (IN for) (NP (JJ hairy-cell) (NN leukemia)))) (, ,)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN rapidity)) (PP (IN of) (NP (NN response)))))))))) (@SINV (, ,) (@SINV ('' '') (@SINV (@SINV (VP (VBZ adds)) (NP (@NP (NP (NNP Elihu) (@NP (NNP H.) (NNP Estey))) (, ,)) (NP (NP (DT a) (@NP (NN cancer) (NN researcher))) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (@NP (NP (NNP Texas-M.D.) (@NP (NNP Anderson) (@NP (NNP Cancer) (NNP Center)))) (, ,)) (NP (NNP Houston))))))))) (. .)))))))
(ROOT (S (NP (NNP Dr.) (NNP Estey)) (@S (ADVP (RB recently)) (@S (VP (@VP (VP (VBD began) (S (VP (@VP (VBG treating) (NP (NNS patients))) (PP (IN with) (NP (NN 2-CdA)))))) (CC and)) (VP (VBZ has) (VP (@VP (VBN had) (NP (JJ similar) (NNS results))) (PP (IN with) (NP (CD five) (NNS patients)))))) (. .)))))
(ROOT (S (`` ``) (@S (S (NP (PRP It)) (VP (VBZ 's) (NP (DT a) (@NP (JJ striking) (NN finding))))) (@S (, ,) (@S ('' '') (@S (NP (PRP he)) (@S (VP (VBZ says)) (. .))))))))
(ROOT (S (`` ``) (@S (NP (PRP It)) (@S (@S (VP (@VP (VBZ 's) (ADJP (RB very) (JJ unlikely))) (S (VP (TO to) (VP (VB be) (NP (DT a) (NN fluke)))))) (. .)) ('' '')))))
(ROOT (S (NP (@NP (@NP (NP (JJ Hairy-cell) (NN leukemia)) (, ,)) (ADJP (JJ so-called) (PP (IN because) (PP (IN of) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (DT the) (@NP (JJ cancerous) (NNS cells))) (PP (IN under) (NP (DT the) (NN microscope)))))))))) (, ,)) (@S (VP (@VP (@VP (VBZ affects) (PP (IN about) (NP (NP (CD 6,000) (NNS people)) (PP (IN in) (NP (DT the) (NNP U.S.)))))) (, ,)) (PP (IN with) (NP (NP (CD 600) (@NP (JJ new) (NNS cases))) (NP (DT a) (NN year))))) (. .))))
(ROOT (S (SBAR (IN As) (S (NP (DT the) (NN disease)) (VP (VBZ progresses)))) (@S (, ,) (@S (NP (NNS patients)) (@S (VP (@VP (@VP (@VP (VP (VBP become) (ADJP (JJ anemic))) (, ,)) (VP (VBP are) (ADJP (JJ vulnerable) (PP (TO to) (NP (NN infection)))))) (CC and)) (VP (ADVP (RB often)) (@VP (VBP need) (NP (NN blood) (NNS transfusions))))) (. .))))))
(ROOT (S (PP (IN Until) (NP (DT the) (NNS mid-1980s))) (@S (, ,) (@S (@S (@S (@S (S (NP (NNS treatments)) (VP (VBD were) (ADJP (JJ ineffective)))) (, ,)) (CC and)) (S (NP (NNS patients)) (@S (ADVP (RB often)) (VP (VBD died) (PP (IN of) (NP (NN blood) (@NP (@NP (NNS problems) (CC and)) (NNS infections)))))))) (. .)))))
(ROOT (S (PP (IN Since) (NP (RB then))) (@S (, ,) (@S (NP (@NP (NP (NN alpha) (NN interferon)) (, ,)) (NP (NP (DT a) (NN drug)) (VP (VBN sold) (PP (IN by) (NP (@NP (NP (NNP Hoffmann-La) (@NP (NNP Roche) (@NP (NNP Inc.) (@NP (CC and) (@NP (NNP Schering-Plough) (NNP Corp.)))))) (CC and)) (NP (NP (DT an) (@NP (JJ experimental) (NN drug))) (VP (VBN called) (NP (NN deoxycoformycin))))))))) (@S (VP (@VP (VBP have) (ADVP (RB significantly))) (VP (@VP (VBN reduced) (NP (NN death) (NNS rates))) (PP (IN from) (NP (JJ hairy-cell) (NN leukemia))))) (. .))))))
(ROOT (S (NP (NNP Hoffmann-La) (NNP Roche)) (@S (VP (VBZ is) (NP (NP (DT the) (@NP (NNP U.S.) (NN subsidiary))) (PP (IN of) (NP (NP (NNP F.) (@NP (NNP Hoffmann-La) (@NP (@NP (NNP Roche) (CC &)) (NNP Co.)))) (PP (IN of) (NP (NNP Switzerland))))))) (. .))))
(ROOT (S (S (CC But) (@S (@S (S (NP (DT neither) (NN drug)) (VP (@VP (VBZ is) (ADJP (IN as) (JJ effective))) (SBAR (IN as) (S (NP (NN 2-CdA)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (PP (IN in) (NP (JJ low) (NNS doses))))))))))) (CC and)) (S (NP (DT both)) (VP (MD can) (VP (@VP (VB cause) (NP (JJ such) (@NP (JJ side) (NNS effects)))) (PP (IN as) (NP (@NP (NP (NN nausea)) (, ,)) (NP (@NP (@NP (@NP (NP (VBG vomiting)) (, ,)) (NP (NN skin) (NNS rashes))) (CC and)) (NP (JJ nervous-system) (NNS disorders)))))))))) (@S (, ,) (@S (NP (NNS researchers)) (@S (VP (VBP say)) (. .))))))
(ROOT (SINV (`` ``) (@SINV (S (PP (IN With) (NP (@NP (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NN toxicity)))) (CC and)) (NP (NP (DT the) (NN ease)) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (NP (NNS people)) (VP (VBP go) (PP (IN into) (NP (@NP (@NP (NP (NN remission)) (-LRB- -LCB-)) (PP (IN with) (NP (NN 2-CdA)))) (-RRB- -RCB-))))))))) (@S (, ,) (@S (NP (PRP I)) (VP (VBP think) (SBAR (S (NP (EX there)) (VP (VBZ 's) (NP (NP (NN something)) (VP (ADVP (RB really)) (@VP (VBG going) (PP (IN on) (NP (RB here))))))))))))) (@SINV (, ,) (@SINV ('' '') (@SINV (@SINV (VP (VBZ says)) (NP (@NP (NP (NNP Ellin) (NNP Berman)) (, ,)) (NP (NP (DT a) (@NP (NN staff) (@NP (NN leukemia) (NN doctor)))) (PP (IN at) (NP (@NP (NP (NNP Memorial) (@NP (NNP Sloan) (@NP (NNP Kettering) (@NP (NNP Cancer) (NNP Center))))) (, ,)) (NP (NNP New) (NNP York))))))) (. .)))))))
(ROOT (S (NP (NNP Scripps)) (@S (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (@VP (@VP (@VP (VBD negotiated) (NP (DT an) (NN agreement))) (PP (IN with) (NP (NP (DT a) (NN subsidiary)) (PP (IN of) (NP (NNP Johnson) (@NP (CC &) (@NP (NNP Johnson) (@NP (PRN (, ,) (@PRN (NP (NNP New) (NNP Brunswick)) (, ,))) (NNP N.J.))))))))) (, ,)) (S (VP (TO to) (VP (@VP (@VP (@VP (VB produce) (CC and)) (VB distribute)) (NP (NP (NN 2-CdA)) (PP (TO to) (NP (JJ other) (NNS centers))))) (PP (IN for) (NP (JJR broader) (@NP (JJ clinical) (NNS trials))))))))))) (. .))))
(ROOT (S (NP (DT The) (NNS researchers)) (@S (VP (@VP (@VP (VP (VBD said) (SBAR (S (NP (DT the) (NN drug)) (VP (VBZ is) (ADJP (JJ easy) (S (VP (TO to) (VP (VB produce))))))))) (CC and)) (ADVP (RB thus))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (RBR less) (@ADJP (JJ expensive) (PP (IN than) (NP (JJ other) (@NP (NN cancer) (NNS treatments)))))))))))) (. .))))
(ROOT (S (PP (IN In) (NP (DT the) (@NP (JJ 12-patient) (NN study)))) (@S (, ,) (@S (NP (@NP (@NP (NP (NN 2-CdA)) (, ,)) (ADJP (JJ short) (PP (IN for) (NP (NN 2-chlorodeoxyadenosine))))) (, ,)) (@S (VP (VBD was) (VP (@VP (@VP (VBN administered) (ADVP (RB continuously))) (PP (IN for) (NP (CD seven) (NNS days)))) (PP (TO to) (NP (NP (NNS patients)) (ADJP (JJ aged) (NP (QP (@QP (CD 36) (TO to)) (CD 61)))))))) (. .))))))
(ROOT (S (S (@S (@S (S (PP (IN Within) (NP (QP (@QP (CD eight) (TO to)) (CD 10)) (NNS weeks))) (@S (, ,) (@S (NP (NP (CD 11)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (@VP (VBD had) (NP (NP (DT no) (NN trace)) (PP (IN of) (NP (NN cancer))))) (PP (IN in) (NP (NP (PRP$ their) (@NP (NN blood) (@NP (CC or) (@NP (NN bone) (NN marrow))))) (SBAR (S (NP (DT the) (JJ 12th)) (VP (VBD had) (NP (NP (DT a) (@NP (JJ small) (@NP (NN amount) (VBG remaining)))) (PP (IN in) (NP (DT the) (NN marrow))))))))))))) (, ,)) (CC but)) (S (NP (PRP he)) (VP (VBD declined) (NP (JJ further) (@NP (NN bone) (@NP (NN marrow) (NN monitoring))))))) (@S (, ,) (@S (NP (NNP Dr.) (NNP Piro)) (@S (VP (VBD said)) (. .))))))
(ROOT (S (S (NP (PRP$ His) (@NP (NN blood) (NNS tests))) (VP (VBP are) (ADJP (JJ normal)))) (@S (, ,) (@S (NP (NNP Dr.) (NNP Piro)) (@S (VP (VBD added)) (. .))))))
(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS patients)))) (@S (VP (VBP have) (VP (@VP (@VP (VBN had) (NP (NP (DT a) (NN relapse)) (SBAR (S (NP (JJ complete) (NN remission)) (VP (VBZ has) (VP (@VP (VBN lasted) (PP (IN from) (NP (QP (@QP (CD seven) (TO to)) (CD 46)) (NNS months)))) (PP (IN after) (NP (NN treatment))))))))) (, ,)) (PP (VBG according) (PP (TO to) (NP (DT the) (NN study)))))) (. .))))
(ROOT (S (`` ``) (@S (S (SBAR (WHADVP (WRB When)) (S (NP (PRP you)) (VP (MD can) (VP (VB make) (S (NP (PDT all) (@NP (DT the) (NN disease))) (VP (@VP (VB go) (ADVP (RB away))) (PP (IN with) (NP (NP (DT a) (@NP (JJ single) (NN infusion))) (PP (IN of) (NP (NN therapy))))))))))) (@S (, ,) (@S (NP (PRP you)) (VP (VBP have) (NP (NP (DT a) (NN disease)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB be) (VP (VBN cured))))))))))))))) (@S (, ,) (@S ('' '') (@S (NP (NNP Dr.) (NNP Piro)) (@S (VP (VBD said)) (. .))))))))
(ROOT (S (CC But) (@S (SBAR (IN because) (S (NP (JJ hairy-cell) (NN leukemia)) (VP (VBZ proliferates) (ADVP (RB slowly))))) (@S (, ,) (@S (NP (DT a) (NN relapse)) (@S (VP (MD could) (VP (@VP (VB occur) (ADVP (RB long))) (PP (IN after) (NP (NN treatment))))) (. .)))))))
(ROOT (S (NP (JJR Longer) (NN follow-up)) (@S (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (NN 2-CdA)) (ADVP (RB actually))) (NP (NP (NNS cures)) (NP (DT the) (NN disease)))))))))) (. .))))
(ROOT (SINV (S (NP (DT The) (NN drug)) (VP (@VP (VBD was) (ADVP (RB first))) (VP (@VP (@VP (VBN made) (PP (IN about) (ADVP (NP (CD 10) (NNS years)) (RB ago)))) (PP (IN at) (NP (NNP Scripps)))) (PP (IN by) (NP (@NP (NP (NNP Dennis) (@NP (NNP A.) (NNP Carson))) (, ,)) (SBAR (WHNP (WP who)) (S (VP (VBD studied) (NP (JJ severe) (@NP (JJ combined) (@NP (NN immunodeficiency) (NN disease)))))))))))) (@SINV (, ,) (@SINV (@SINV (VP (VBD made) (S (ADJP (JJ famous)))) (NP (@NP (NP (DT a) (@NP (JJ few) (NNS years))) (ADVP (RB ago) (PP (IN by) (NP (DT the) (@NP (NNP Texas) (NN boy)))))) (SBAR (WHNP (WDT that)) (S (VP (VBD lived) (PP (IN in) (NP (DT a) (NN bubble)))))))) (. .)))))
(ROOT (S (NP (NP (NNS People)) (PP (IN with) (NP (DT that) (NN disease)))) (@S (VP (VBP lack) (NP (NP (DT an) (NN enzyme)) (SBAR (WHNP (WDT that)) (S (VP (VBZ processes) (NP (@NP (NP (NN deoxyadenosine)) (, ,)) (NP (NP (DT a) (NN chemical)) (SBAR (WHNP (IN that)) (S (, ,) (@S (PP (IN without) (NP (DT the) (NN enzyme))) (@S (, ,) (VP (@VP (VP (@VP (VBZ builds) (PRT (RP up))) (PP (IN in) (NP (NN infection-fighting) (@NP (JJ white) (@NP (NN blood) (NNS cells)))))) (CC and)) (VP (VBZ kills) (NP (PRP them))))))))))))))) (. .))))
(ROOT (S (SBAR (IN Since) (S (NP (NN cancer) (NNS patients)) (VP (VBP have) (NP (DT the) (NN enzyme))))) (@S (, ,) (@S (NP (NNP Scripps) (NNS scientists)) (@S (VP (VBD developed) (NP (NP (DT a) (NN compound)) (SBAR (WHNP (WDT that)) (S (VP (@VP (@VP (VP (VBZ mimics) (NP (NN deoxyadenosine))) (, ,)) (CC but)) (VP (NP (NP (NNS tricks)) (NP (DT the) (NN enzyme))) (SBAR (IN so) (S (NP (PRP it)) (VP (@VP (MD ca) (RB n't)) (VP (VB be) (VP (VBN processed)))))))))))) (. .))))))
(ROOT (S (NP (DT The) (NN compound)) (@S (ADVP (RB then)) (@S (VP (VBZ kills) (NP (@NP (NP (DT the) (@NP (JJ white) (@NP (NN blood) (NNS cells)))) (, ,)) (PP (VBG including) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ cancerous))))))))) (. .)))))
(ROOT (S (NP (ADJP (NNP New) (@ADJP (, ,) (JJ normal))) (@NP (JJ white) (NNS cells))) (@S (VP (@VP (VBP are) (ADVP (RB then))) (VP (VBN generated) (PP (IN in) (NP (DT the) (@NP (NN bone) (NN marrow)))))) (. .))))
(ROOT (SINV (S (SBAR (IN Because) (S (NP (JJ hairy-cell) (NN leukemia)) (VP (VBZ is) (ADJP (JJ rare))))) (@S (, ,) (@S (NP (DT a) (@NP (JJ 12-patient) (NN study))) (@S (`` ``) (@S (@S (VP (VBZ is) (VP (VBN considered) (NP (DT a) (@NP (ADJP (RB pretty) (JJ good)) (NN series))))) (, ,)) ('' '')))))) (@SINV (@SINV (VP (VBZ says)) (NP (NP (NN Sloan-Kettering) (POS 's)) (@NP (NNP Dr.) (NNP Berman)))) (. .))))
(ROOT (S (`` ``) (@S (@S (@S (@S (@S (S (NP (PRP It)) (VP (@VP (VBZ 's) (ADJP (JJ ironic))) (SBAR (IN that) (S (NP (PRP we)) (VP (VBP have) (NP (NP (CD three) (@NP (JJ active) (NNS drugs))) (PP (IN for) (NP (NP (DT a) (NN disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ 's) (ADJP (RB fairly) (JJ rare))))))))))))) (, ,)) (CC but)) (S (PP (IN for) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (@NP (ADJP (RBR more) (JJ common)) (NNS forms))) (PP (IN of) (NP (NN leukemia))))))) (@S (, ,) (@S (NP (PRP we)) (VP (@VP (@VP (VBP do) (RB n't)) (ADVP (RB yet))) (VP (VB have) (NP (JJ good) (NNS treatments)))))))) (. .)) ('' ''))))
(ROOT (S (NP (NNP Dr.) (NNP Piro)) (@S (VP (VBD said) (SBAR (S (NP (NN 2-CdA)) (VP (@VP (VBZ has) (ADVP (RB also))) (VP (VBN been) (VP (@VP (@VP (@VP (@VP (VBN used) (ADVP (RB effectively))) (PP (IN in) (NP (JJ initial) (NNS trials)))) (S (VP (TO to) (VP (VB treat) (NP (JJR more) (@NP (JJ common) (NNS cancers))))))) (, ,)) (PP (VBG including) (NP (@NP (@NP (@NP (NP (JJ chronic) (@NP (JJ lymphocytic) (NN leukemia))) (, ,)) (NP (JJ non-Hodgkins) (NN lymphoma))) (CC and)) (NP (JJ cutaneous) (@NP (NN T-cell) (NN lymphoma))))))))))) (. .))))
(ROOT (S (PP (IN About) (NP (NP (NP (QP (CD 50) (@QP (@QP (@QP (NN %) (TO to)) (CD 60)) (NN %)))) (PP (IN of) (NP (NP (NNS patients)) (PRN (: --) (@PRN (SBAR (WHNP (JJS most) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD had) (VP (VBN failed) (NP (JJ other) (NNS treatments)))))) (: --)))))) (VP (@VP (VBD responded) (PP (TO to) (NP (@NP (NP (DT the) (NN drug)) (, ,)) (NP (DT some))))) (PP (IN with) (NP (JJ complete) (NN remission)))))) (@S (, ,) (@S (NP (PRP he)) (@S (VP (VBD said)) (. .))))))
(ROOT (S (`` ``) (@S (S (ADVP (RB Now)) (@S (, ,) (@S (NP (PRP we)) (VP (MD will) (VP (@VP (@VP (@VP (VB use) (-LRB- -LCB-)) (NP (NN 2-CdA))) (-RRB- -RCB-)) (PP (IN as) (NP (DT a) (@NP (JJ first) (@NP (NN treatment) (S (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP (@NP (NN response) (CC and)) (NN remission)) (VP (VBP are) (ADJP (JJR higher))))))))))))))))) (@S (, ,) (@S ('' '') (@S (NP (PRP he)) (@S (VP (VBD said)) (. .))))))))
(ROOT (S (ADVP (RB Meanwhile)) (@S (, ,) (@S (NP (NP (NNS researchers)) (PP (IN at) (NP (NP (NNP University)) (PP (IN of) (NP (NP (NNP California)) (PP (IN at) (NP (NNP San) (NNP Francisco)))))))) (@S (VP (VBP are) (VP (@VP (VBG testing) (NP (NN 2-CdA))) (PP (IN on) (NP (JJ AIDS-related) (NN lymphoma))))) (. .))))))
